江西去年处理违法违规医药机构16687家 追回医保资金超7亿元

2021-04-03 吴鹏泉 中国新闻网

记者19日从江西省医疗保障局获悉,该省2020年共处理违法违规医药机构16687家,追回医保资金7.23亿元。

记者19日从江西省医疗保障局获悉,该省2020年共处理违法违规医药机构16687家,追回医保资金7.23亿元。

医疗保障是减轻群众就医负担、增进民生福祉、维护社会和谐稳定的重大制度安排。近年来,江西省经济社会的持续快速发展,为完善医疗保障制度体系提供了强大动力,各项改革持续推进,在破解看病难、看病贵问题上取得了积极进展。

据了解,江西省医疗保障局成立以来,进一步健全完善了该省统一的城乡居民基本医疗保险制度,建立了全省统一的职工基本医疗保险和大病保险制度,制度公平性和群众获得感不断提升,城乡居民医保政策范围内报销比例达到70%左右。

统计数据显示,2020年,江西医保扶贫政策资助农村建档贫困人口参保281.6万人,减轻个人参保缴费负担近8亿元;全面落实了三批次国家组织药品集中采购中选结果,累计节约采购资金超过33亿元。

江西省医疗保障局相关负责人介绍说,随着人民群众对健康福祉美好生活需求日益增长,医疗保障领域发展不平衡不充分的问题逐步显现,制度碎片化、待遇不均衡、保障有短板、监管有漏洞、服务不到位等情况依然存在,必须通过深化改革加以解决。

2020年12月21日召开的江西省委全面深化改革委员会第十三次会议,审议通过了《中共江西省委江西省人民政府关于深化医疗保障制度改革的实施意见》(以下简称《实施意见》)。2021年1月21日,以江西省委、省政府名义正式印发实施。

《实施意见》提出,加快补齐江西省医疗保障领域体制机制短板,着力构建以基本医疗保险为主体,医疗救助为托底,补充医疗保险、商业健康保险、慈善捐赠、医疗互助共同发展的多层次医疗保障制度体系。

《实施意见》要求,在完善基本医疗保险制度上,提出完善全省统一的基本医疗保险政策、推进个人账户制度改革、健全门诊统筹制度;针对医疗救助对象识别缺乏精准性等问题,强调通过多部门联动,建立救助对象精准识别机制;针对江西基本医疗保险和商业健康保险未形成合力问题,提出鼓励商业保险开发与基本医疗保险相衔接的产品;结合江西医保制度在应对新冠疫情中的有益探索,提出完善重大疫情医疗保障应急机制的具体方式,包括应对重大公共卫生事件中,有针对性免除医保目录、支付限额、用药量等限制性条款等措施。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1776915, encodeId=ecb61e769150e, content=<a href='/topic/show?id=3baf9449415' target=_blank style='color:#2F92EE;'>#违法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94494, encryptionId=3baf9449415, topicName=违法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a65839047655, createdName=dinorsor537, createdTime=Thu Mar 03 23:25:44 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1747762, encodeId=96a31e4776242, content=<a href='/topic/show?id=528294510d4' target=_blank style='color:#2F92EE;'>#违规#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94510, encryptionId=528294510d4, topicName=违规)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe7b35947177, createdName=zhao4628, createdTime=Wed May 05 16:25:44 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719711, encodeId=17601e197114b, content=<a href='/topic/show?id=a29335349f4' target=_blank style='color:#2F92EE;'>#医药机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35349, encryptionId=a29335349f4, topicName=医药机构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=078f32798664, createdName=cenghis, createdTime=Tue Jan 04 12:25:44 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410120, encodeId=6cf01410120b6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Apr 05 06:25:44 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953585, encodeId=41b4953585e0, content=这种事情小地方太多了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/5ff406be14214a2382446bee2a6a5a17/d86ca8b32a014802a07fb644f93b3a73.jpg, createdBy=90132272125, createdName=121a9258m18暂无昵称, createdTime=Sat Apr 03 17:38:50 CST 2021, time=2021-04-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1776915, encodeId=ecb61e769150e, content=<a href='/topic/show?id=3baf9449415' target=_blank style='color:#2F92EE;'>#违法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94494, encryptionId=3baf9449415, topicName=违法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a65839047655, createdName=dinorsor537, createdTime=Thu Mar 03 23:25:44 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1747762, encodeId=96a31e4776242, content=<a href='/topic/show?id=528294510d4' target=_blank style='color:#2F92EE;'>#违规#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94510, encryptionId=528294510d4, topicName=违规)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe7b35947177, createdName=zhao4628, createdTime=Wed May 05 16:25:44 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719711, encodeId=17601e197114b, content=<a href='/topic/show?id=a29335349f4' target=_blank style='color:#2F92EE;'>#医药机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35349, encryptionId=a29335349f4, topicName=医药机构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=078f32798664, createdName=cenghis, createdTime=Tue Jan 04 12:25:44 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410120, encodeId=6cf01410120b6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Apr 05 06:25:44 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953585, encodeId=41b4953585e0, content=这种事情小地方太多了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/5ff406be14214a2382446bee2a6a5a17/d86ca8b32a014802a07fb644f93b3a73.jpg, createdBy=90132272125, createdName=121a9258m18暂无昵称, createdTime=Sat Apr 03 17:38:50 CST 2021, time=2021-04-03, status=1, ipAttribution=)]
    2021-05-05 zhao4628
  3. [GetPortalCommentsPageByObjectIdResponse(id=1776915, encodeId=ecb61e769150e, content=<a href='/topic/show?id=3baf9449415' target=_blank style='color:#2F92EE;'>#违法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94494, encryptionId=3baf9449415, topicName=违法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a65839047655, createdName=dinorsor537, createdTime=Thu Mar 03 23:25:44 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1747762, encodeId=96a31e4776242, content=<a href='/topic/show?id=528294510d4' target=_blank style='color:#2F92EE;'>#违规#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94510, encryptionId=528294510d4, topicName=违规)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe7b35947177, createdName=zhao4628, createdTime=Wed May 05 16:25:44 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719711, encodeId=17601e197114b, content=<a href='/topic/show?id=a29335349f4' target=_blank style='color:#2F92EE;'>#医药机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35349, encryptionId=a29335349f4, topicName=医药机构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=078f32798664, createdName=cenghis, createdTime=Tue Jan 04 12:25:44 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410120, encodeId=6cf01410120b6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Apr 05 06:25:44 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953585, encodeId=41b4953585e0, content=这种事情小地方太多了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/5ff406be14214a2382446bee2a6a5a17/d86ca8b32a014802a07fb644f93b3a73.jpg, createdBy=90132272125, createdName=121a9258m18暂无昵称, createdTime=Sat Apr 03 17:38:50 CST 2021, time=2021-04-03, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1776915, encodeId=ecb61e769150e, content=<a href='/topic/show?id=3baf9449415' target=_blank style='color:#2F92EE;'>#违法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94494, encryptionId=3baf9449415, topicName=违法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a65839047655, createdName=dinorsor537, createdTime=Thu Mar 03 23:25:44 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1747762, encodeId=96a31e4776242, content=<a href='/topic/show?id=528294510d4' target=_blank style='color:#2F92EE;'>#违规#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94510, encryptionId=528294510d4, topicName=违规)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe7b35947177, createdName=zhao4628, createdTime=Wed May 05 16:25:44 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719711, encodeId=17601e197114b, content=<a href='/topic/show?id=a29335349f4' target=_blank style='color:#2F92EE;'>#医药机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35349, encryptionId=a29335349f4, topicName=医药机构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=078f32798664, createdName=cenghis, createdTime=Tue Jan 04 12:25:44 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410120, encodeId=6cf01410120b6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Apr 05 06:25:44 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953585, encodeId=41b4953585e0, content=这种事情小地方太多了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/5ff406be14214a2382446bee2a6a5a17/d86ca8b32a014802a07fb644f93b3a73.jpg, createdBy=90132272125, createdName=121a9258m18暂无昵称, createdTime=Sat Apr 03 17:38:50 CST 2021, time=2021-04-03, status=1, ipAttribution=)]
    2021-04-05 cathymary
  5. [GetPortalCommentsPageByObjectIdResponse(id=1776915, encodeId=ecb61e769150e, content=<a href='/topic/show?id=3baf9449415' target=_blank style='color:#2F92EE;'>#违法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94494, encryptionId=3baf9449415, topicName=违法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a65839047655, createdName=dinorsor537, createdTime=Thu Mar 03 23:25:44 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1747762, encodeId=96a31e4776242, content=<a href='/topic/show?id=528294510d4' target=_blank style='color:#2F92EE;'>#违规#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94510, encryptionId=528294510d4, topicName=违规)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe7b35947177, createdName=zhao4628, createdTime=Wed May 05 16:25:44 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719711, encodeId=17601e197114b, content=<a href='/topic/show?id=a29335349f4' target=_blank style='color:#2F92EE;'>#医药机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35349, encryptionId=a29335349f4, topicName=医药机构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=078f32798664, createdName=cenghis, createdTime=Tue Jan 04 12:25:44 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410120, encodeId=6cf01410120b6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Apr 05 06:25:44 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953585, encodeId=41b4953585e0, content=这种事情小地方太多了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/5ff406be14214a2382446bee2a6a5a17/d86ca8b32a014802a07fb644f93b3a73.jpg, createdBy=90132272125, createdName=121a9258m18暂无昵称, createdTime=Sat Apr 03 17:38:50 CST 2021, time=2021-04-03, status=1, ipAttribution=)]
    2021-04-03 121a9258m18暂无昵称

    这种事情小地方太多了

    0

相关资讯

辽宁:3111家医药机构因违规使用医保基金被处理

辽宁省医保局近日宣布,全省3111家定点医药机构因违规使用医保基金,被予以解除定点协议、暂停医保服务等处理。据辽宁省医保局介绍,2018年底以来,辽宁在全省范围内开展了打击医疗保险欺诈骗保专项行动。有关部门整合医保、卫健、公安、审计、药监等多部门力量,共成立100多个联合检查组,出动万余人次进行现场检查,运用大数据分析和智能监控手段进行筛查,并对重复住院、雷同病例等疑点信息进行重点筛查。经筛查发现

追回千万医保基金!一大批违规医药机构被处理

在2019年打击欺诈骗保专项治理中,山西省共检查定点医药机构9670家,处理违规医药机构1185家(其中移交司法机关3家),累计追回医保基金1234.28万元。

国家医保局:医药机构欺诈骗保将被解除定点协议

国家医保局日前印发《关于当前加强医保协议管理确保基金安全有关工作的通知》,要求各地医保经办机构加强对定点医药机构的协议管理,确保医保基金安全。

甘肃查处医保系统1637家医药机构 守护民众“救命钱”

记者6日从甘肃省打击欺诈骗保专项治理及“两险合并实施”新闻发布会上获悉,甘肃在全省开展打击欺诈骗保专项治理,截至今年9月,全省医保系统共检查定点医药机构16930家,查处1637家,解除协议150家,暂停协议496家,行政罚款81家,约谈和责令整改等909家,移交司法机关1家,追回基金、扣减违约金、行政罚款等合计5725.12万元。甘肃省医疗保障局党组成员、副局长冯连宝介绍说,该局对全省医保系统定

首创!福州医药机构医保定点实行备案管理

“医保定点管理模式变为备案管理,不再对已经相关行政主管部门批准设立的医药机构设置前置条件”

省级层面首次出台“医药机构失信惩戒办法”,13项失信行为重点纳入

近日,江苏省医疗保障局联合江苏省社会信用体系建设领导小组办公室共同印发《江苏省医疗保障定点医药机构失信行为惩戒暂行办法》(下简称“办法”),将于2020年3月1日起施行。 坚决打击欺诈骗保行为,切实保障基金安全。此前于2019年2月,国家医保局印发《关于做好2019年医疗保障基金监管工作的通知》,明确提出,要结合诚信体系建设试点,探索建立严重违规定点医药机构、医保医师和参保人员“黑名单”